You Are On:
EQUITY
Equity Analysis
  Price
    Gainers & Losers
    Out & Under Performers
    Only Buyers & Sellers
     Advances & Declines
     New Highs & Lows
     Weightage
     5 Day's Up & Down
  Volume
  Analysis
News Analysis
Corporate Info
Corporate Action
Other Market
Quarterly Results    
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 329.19
NSE Code AUROPHARMA
Dividend Yield(%) 0.27
Market Cap(Million) 640430.90
P/E(X) 32.57
EPS(Rs.) 33.56
Face Value(Rs.) 1  
Type Quarters :
(Rs. in Million)
Particulars (Rs in Million) Dec 2023Sep 2023Jun 2023Mar 2023
 Audited / UnAudited UnAudited UnAudited UnAudited Audited
Net Sales 73517.80 72194.20 68505.20 64729.60
Total Expenditure 57504.70 58459.80 56991.50 54707.80
PBIDT (Excl OI) 16013.10 13734.40 11513.70 10021.80
Other Income 1625.20 1869.80 1163.30 1349.10
Operating Profit 17638.30 15604.20 12677.00 11370.90
Interest 755.50 681.80 565.50 556.00
Exceptional Items 0 0 -697.50 0
PBDT 16882.80 14922.40 11414.00 10814.90
Depreciation 4232.70 4175.00 3265.60 3455.70
Profit Before Tax 12650.10 10747.40 8148.40 7359.20
Tax 3224.50 3237.00 2423.20 2241.50
Provisions and contingencies 0 0 0 0
Profit After Tax 9425.60 7510.40 5725.20 5117.70
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0 0 0 0
Net Profit 9425.60 7510.40 5725.20 5117.70
Minority Interest -36.80 52.40 10.40 3.60
Shares of Associates -25.9 9 -28.1 -58.6
Other related items    
Misc. Expenses Written off 0 0 0 0
Consolidated Net Profit 9362.90 7571.80 5707.50 5062.70
Equity Capital 585.90 585.90 585.90 585.90
Face Value (IN RS) 1.00 1.00 1.00 1.00
Reserves 0 0 0 0
Calculated EPS 15.98 12.92 9.74 8.64
Calculated EPS (Annualised) 63.92 51.69 38.97 34.56
No of Public Share Holdings 282223138.00 282223138.00 282223138.00 282223138.00
% of Public Share Holdings 48.17 48.17 48.17 48.17
     
PBIDTM% (Excl OI) 21.78 19.02 16.81 15.48
PBIDTM% 23.99 21.61 18.51 17.57
PBDTM% 22.96 20.67 16.66 16.71
PBTM% 17.21 14.89 11.89 11.37
PATM% 12.82 10.40 8.36 7.91
 Notes Notes Notes Notes